Assenagon Asset Management S.A. Has $6.92 Million Stock Holdings in PetIQ, Inc. (NASDAQ:PETQ)

Assenagon Asset Management S.A. trimmed its holdings in PetIQ, Inc. (NASDAQ:PETQ - Free Report) by 16.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 350,169 shares of the company's stock after selling 66,709 shares during the quarter. Assenagon Asset Management S.A. owned 1.19% of PetIQ worth $6,916,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of the company. BlackRock Inc. raised its stake in shares of PetIQ by 1.2% in the first quarter. BlackRock Inc. now owns 2,510,747 shares of the company's stock valued at $61,262,000 after purchasing an additional 29,457 shares in the last quarter. Vanguard Group Inc. raised its stake in PetIQ by 13.4% during the third quarter. Vanguard Group Inc. now owns 1,918,500 shares of the company's stock worth $37,794,000 after acquiring an additional 226,718 shares in the last quarter. Aristotle Capital Boston LLC raised its stake in PetIQ by 2.3% during the second quarter. Aristotle Capital Boston LLC now owns 1,283,220 shares of the company's stock worth $19,466,000 after acquiring an additional 28,631 shares in the last quarter. Capital Research Global Investors raised its stake in PetIQ by 199.5% during the first quarter. Capital Research Global Investors now owns 1,051,358 shares of the company's stock worth $25,653,000 after acquiring an additional 700,358 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in PetIQ by 24.4% during the second quarter. Dimensional Fund Advisors LP now owns 717,569 shares of the company's stock worth $10,886,000 after acquiring an additional 140,630 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

PetIQ Trading Up 4.8 %

PetIQ stock traded up $0.84 during mid-day trading on Friday, hitting $18.28. The stock had a trading volume of 350,928 shares, compared to its average volume of 379,287. The company has a current ratio of 2.27, a quick ratio of 1.43 and a debt-to-equity ratio of 1.97. PetIQ, Inc. has a 12 month low of $10.78 and a 12 month high of $22.98. The stock has a market capitalization of $537.98 million, a PE ratio of 304.72 and a beta of 1.65. The stock has a 50-day simple moving average of $17.63 and a two-hundred day simple moving average of $18.59.

PetIQ (NASDAQ:PETQ - Get Free Report) last issued its earnings results on Wednesday, February 28th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.38) by $0.22. PetIQ had a return on equity of 11.72% and a net margin of 0.19%. The firm had revenue of $219.93 million for the quarter, compared to analysts' expectations of $189.70 million. As a group, sell-side analysts forecast that PetIQ, Inc. will post 0.94 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised their target price on PetIQ from $24.00 to $28.00 and gave the company a "buy" rating in a research note on Tuesday, March 19th. Four equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $29.00.

PetIQ Company Profile

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.